Safety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures-an open-label trial

Focal (partial onset) seizures are often treated similarly in children over 4 years of age and in adolescent or adult patients [1,2]. As in adults, over 25% of children have inadequate seizure control on currently available antiepileptic drugs (AEDs), or have experienced significant adverse drug effects [3,4]. In general, there are fewer data from randomized controlled trials to guide the treatment of epilepsy in pediatric patients compared with adults [5].

0